Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders-Reference-Cited by-同舟云学术

Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders

Published:2006-02 Issue:2 Volume:3 Page:101-110
ISSN:1743-4270
Container-title:Nature Clinical Practice Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Steers William D,Tuttle Jeremy B

Publisher

Springer Science and Business Media LLC

Subject

Urology,General Medicine

Link

http://www.nature.com/articles/ncpuro0408.pdf

Reference69 articles.

1. Levi-Montalcini R and Angeletti PU (1966) Second symposium on catecholamines. Modification of sympathetic function. Immunosympathectomy. Pharmacol Rev 18: 619–628

2. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237: 1154–1162

3. Johnson EM Jr et al. (1980) Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 219: 916–918

4. Dupont MC et al. (2001) Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 166: 1111–1118

5. Tuttle JB et al. (1994) Neural input regulates tissue NGF and growth of the adult urinary bladder. J Auton Nerv Syst 49: 147–158

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet-rich plasma attenuates the UPEC-induced cystitis via inhibiting MMP-2,9 activities and downregulation of NGF and VEGF in Canis Lupus Familiaris model;Scientific Reports;2024-06-13

2. Role of Intravesical Ozone in the Management of BPS/Interstitial Cystitis;Current Bladder Dysfunction Reports;2023-10-13

3. Molecular Mechanisms of Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury;International Journal of Molecular Sciences;2023-04-26

4. Neurogenic Lower Urinary Tract Dysfunction in Spinal Dysraphism: Morphological and Molecular Evidence in Children;International Journal of Molecular Sciences;2023-02-12

5. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment;Toxins;2023-02-02